0001415889-23-002458.txt : 20230214 0001415889-23-002458.hdr.sgml : 20230214 20230214164613 ACCESSION NUMBER: 0001415889-23-002458 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230210 FILED AS OF DATE: 20230214 DATE AS OF CHANGE: 20230214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laccona Nicholas CENTRAL INDEX KEY: 0001886497 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 23630775 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 form4-02142023_040248.xml X0306 4 2023-02-10 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001886497 Laccona Nicholas 184 LIBERTY CORNER ROAD SUITE 302 WARREN NJ 07059 false true false false FINANCIAL OFFICER, (PFO & PAO) Stock Options (right to buy) 1.52 2023-02-10 4 A 0 50000 1.52 A 2033-02-10 Common Stock 50000 50000 D This option vests as to 25% of the underlying shares on February 10, 2024 and the remaining options vest quarterly over a period of 3 years thereafter. /s/ Nicholas Laccona 2023-02-14